Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$770M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$580M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$391M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$322M |
| 5 |
UnitedHealth
UNH
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.21B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 3 |
RP
RealPage, Inc.
RP
|
+$316M |
| 4 |
Shopify
SHOP
|
+$312M |
| 5 |
Boeing
BA
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.82% |
| 2 | Healthcare | 7.16% |
| 3 | Financials | 5.78% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Industrials | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVA
3826
DELISTED
Covanta Holding Corporation
CVA
| $2.16M | ﹤0.01% |
122,669
+84,733
| +223% | +$1.29M |
|
3827
iShares US Transportation ETF
IYT
$2.26B
| $2.16M | ﹤0.01% |
+33,228
| New | +$2.22M |
|
|
HGAS
3828
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
| $2.16M | ﹤0.01% |
+220,727
| New | +$2.16M |
|
3829
Agilysys
AGYS
$2.97B
| $2.16M | ﹤0.01% |
37,923
+26,137
| +222% | +$1.35M |
|
3830
Viridian Therapeutics
VRDN
$2.09B
| $2.15M | ﹤0.01% |
117,715
+74,539
| +173% | +$1.28M |
|
|
FATH
3831
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $2.15M | ﹤0.01% |
+11,076
| New | +$2.17M |
|
|
CFFEU
3832
DELISTED
CF Acquisition Corp. VIII Unit
CFFEU
| $2.15M | ﹤0.01% |
212,595
-342,405
| -62% | -$3.43M |
|
|
OPTN
3833
DELISTED
OptiNose
OPTN
| $2.15M | ﹤0.01% |
45,983
+41,560
| +940% | +$2.12M |
|
|
CALB
3834
DELISTED
California BanCorp Common Stock
CALB
| $2.14M | ﹤0.01% |
+114,653
| New | +$2.05M |
|
3835
United Bankshares
UBSI
$6.63B
| $2.14M | ﹤0.01% |
58,715
-130,908
| -69% | -$5.14M |
|
3836
Patterson-UTI
PTEN
$3.98B
| $2.14M | ﹤0.01% |
215,491
-491,486
| -70% | -$4.16M |
|
3837
Procore
PCOR
$8.26B
| $2.14M | ﹤0.01% |
+22,531
| New | +$1.98M |
|
3838
Voyager Therapeutics
VYGR
$183M
| $2.14M | ﹤0.01% |
+517,862
| New | +$2.35M |
|
3839
Abeona Therapeutics
ABEO
$366M
| $2.14M | ﹤0.01% |
+54,804
| New | +$2.24M |
|
|
DNB
3840
CALL
DELISTED
Dun & Bradstreet
DNB
| $2.14M | ﹤0.01% |
+100,000
| New | +$2.24M |
|
3841
Hawthorn Bancshares
HWBK
$269M
| $2.14M | ﹤0.01% |
+100,788
| New | +$2.02M |
|
3842
Amkor Technology
AMKR
$12.4B
| $2.14M | ﹤0.01% |
+90,241
| New | +$2.01M |
|
|
BLSA
3843
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $2.13M | ﹤0.01% |
202,710
+18,126
| +10% | +$188K |
|
3844
Alliant Energy
LNT
$18.3B
| $2.13M | ﹤0.01% |
38,272
-508,728
| -93% | -$28.8M |
|
|
TBCH
3845
Turtle Beach Corp
TBCH
$243M
| $2.13M | ﹤0.01% |
66,854
+56,903
| +572% | +$1.72M |
|
3846
Lyell Immunopharma
LYEL
$317M
| $2.13M | ﹤0.01% |
+6,558
| New | +$2.15M |
|
3847
National CineMedia
NCMI
$376M
| $2.13M | ﹤0.01% |
41,995
-2,254
| -5% | -$106K |
|
3848
PUT
SolarEdge
SEDG
$2.51B
| $2.13M | ﹤0.01% |
7,700
-2,500
| -25% | -$630K |
|
3849
OFG Bancorp
OFG
$2.23B
| $2.13M | ﹤0.01% |
96,169
+43,473
| +82% | +$1.03M |
|
3850
Parsons
PSN
$4.72B
| $2.13M | ﹤0.01% |
54,031
-80,345
| -60% | -$3.3M |
|
Similar funds
Millennium Management's Q2 2021 Portfolio in Review
As of Q2 2021, Millennium Management held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management deployed $13.3B of net new capital in Q2 2021, opening 1,693 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.
- Millennium Management's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
- Millennium Management added most to Linde in Q2 2021, an estimated $770M increase.
- Millennium Management's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
- Millennium Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
- Millennium Management's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
- Millennium Management opened 1,693 new positions and closed 1,074 in Q2 2021.
- Millennium Management's portfolio value rose 17% quarter-over-quarter to $163B.
Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.